FDA Inspection 1113169 — Kyowa Hakko Bio Co. Ltd.
The FDA completed an inspection of Kyowa Hakko Bio Co. Ltd. on Nov 8, 2019 in Ube. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 8, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ube (Japan)